Pharmacokinetics of Once Daily Subcutaneous Methylnaltrexone in Neurointensive Care Patients With High Dose Sufentanil Analgosedation
Phase of Trial: Phase I
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Pharmacokinetics
- 25 Oct 2016 Status changed from recruiting to completed.
- 27 Feb 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Sep 2013 Planned initiation date changed from 1 Aug 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.